Carvacrol
CAS 499-75-2
Carvacrol (CAS 499-75-2) is a Phase 2 pharmaceutical compound with 6 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | MIC | 173.99 ug.mL-1 | 36 | - |
| - | MIC | 0.16 %v/v | 4 | - |
| - | IC50 | 34353.333333333336 nM | 3 | - |
| - | EC50 | 13531.956666666665 nM | 2 | - |
| - | EC50 | 0.128 uL/ml | 1 | - |
| - | EC50 | 41 ug.mL-1 | 1 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| TRPM7 Trpm7 |
Inhibition | 3.5199999809265137 pIC50 | 19135721 |
| TRPV3 Trpv3 |
Full agonist | - | 16617338 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Carvacrol used for in pharmaceutical contexts?
Carvacrol (CAS 499-75-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Carvacrol?
No adverse-event association or SIDER side-effect rows are rendered for Carvacrol in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Carvacrol also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Carvacrol with EU status "permitted".
What clinical phase is Carvacrol in?
Carvacrol is rendered with ChEMBL max phase 2.